169 related articles for article (PubMed ID: 24147779)
1. In vitro antifungal susceptibility of clinical isolates of Arthrographis kalrae, a poorly known opportunistic fungus.
Sandoval-Denis M; Giraldo A; Sutton DA; Fothergill AW; Guarro J
Mycoses; 2014 Apr; 57(4):247-8. PubMed ID: 24147779
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates.
Lacroix C; de Chauvin MF
J Antimicrob Chemother; 2008 Apr; 61(4):835-7. PubMed ID: 18218642
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
da Cunha KC; Sutton DA; Fothergill AW; Gené J; Cano J; Madrid H; Hoog Sd; Crous PW; Guarro J
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):168-74. PubMed ID: 23558007
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
Coelho RA; Brito-Santos F; Figueiredo-Carvalho MHG; Silva JVDS; Gutierrez-Galhardo MC; do Valle ACF; Zancopé-Oliveira RM; Trilles L; Meyer W; Freitas DFS; Almeida-Paes R
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006675. PubMed ID: 30048450
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China.
Lei HL; Li LH; Chen WS; Song WN; He Y; Hu FY; Chen XJ; Cai WP; Tang XP
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1099-1102. PubMed ID: 29536323
[TBL] [Abstract][Full Text] [Related]
7.
Maphanga TG; Britz E; Zulu TG; Mpembe RS; Naicker SD; Schwartz IS; Govender NP
J Clin Microbiol; 2017 Jun; 55(6):1812-1820. PubMed ID: 28356416
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.
Seyedmousavi S; Samerpitak K; Rijs AJ; Melchers WJ; Mouton JW; Verweij PE; de Hoog GS
Antimicrob Agents Chemother; 2014 Jun; 58(6):3285-92. PubMed ID: 24687495
[TBL] [Abstract][Full Text] [Related]
11. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
[TBL] [Abstract][Full Text] [Related]
14. [Antifungal susceptibility of clinical isolates of Scopulariopsis species].
Odero V; García-Agudo L; Guerrero I; Aznar P; García-Martos P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2014 Mar; 27(1):17-21. PubMed ID: 24676237
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.
Yao L; Wan Z; Li R; Yu J
Antimicrob Agents Chemother; 2015 Aug; 59(8):5040-3. PubMed ID: 26014943
[TBL] [Abstract][Full Text] [Related]
16. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
17. [In vitro antifungal susceptibility profile of Scopulariopsis brevicaulis isolated from onychomycosis].
Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G
Rev Esp Quimioter; 2015 Aug; 28(4):210-3. PubMed ID: 26200030
[TBL] [Abstract][Full Text] [Related]
18. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis.
Vitale RG; Perez-Blanco M; De Hoog GS
Med Mycol; 2009 Feb; 47(1):35-40. PubMed ID: 19115138
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra.
Badali H; Al-Hatmi AMS; Fakhim H; Moghaddasi A; Khodavaisy S; Vaezi A; Ahangarkani F; de Hoog GS; Meis JF
Int J Antimicrob Agents; 2019 Jul; 54(1):95-98. PubMed ID: 31071468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
